Objective The risk of dementia associated with the use of psychotropic drugs is not fully
understood. A nested case‐control study was carried out to assess the risk of dementia …

Background: Antipsychotics are often used to treat neuropsychiatric symptoms in dementia,
but the evidence for effect is limited. Antipsychotics have been associated with increased …

Objective To investigate short-and long-term mortality risk associated with the use of
antipsychotics in dementia outpatients, assessing the risk over specific time frames and …

Psychotropic drugs are used for treatment of behavioral and psychological symptoms of
dementia (BPSD) although they are associated with serious adverse drug events. Objective …

Purpose Since the beginning of the 21st century, serious adverse events and an increased
risk of mortality have been documented in patients with dementia treated with antipsychotics …

Antipsychotic treatments are associated with safety concerns in people with dementia. The
authors aimed to investigate whether risk of adverse outcomes related to antipsychotic …

Background/Aims: To evaluate whether dementia patients prescribed antipsychotic drugs
have a higher mortality compared to unexposed patients, and to investigate whether there …

Purpose Concomitant use of anti‐dementia drugs with psychotropic drugs is potentially
problematic in patients with dementia. The aim of this study was to investigate how …

BackgroundBehavioural and psychological symptoms of dementia are frequently treated
with antipsychotics. AimsTo determine the incidence of antipsychotic use in relation to …

Background Little is known about the level of psychotropic chronic exposure in all patients
living with dementia. The aim of the study was to quantify chronic psychotropic exposure in …